Monoclonal antibody therapy of B cell lymphoma: Signaling activity on tumor cells appears more important than recruitment of effectors

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 3176-3185

  Tutt, A L ^a   French, R R ^a   Illidge, T M ^a   Honeychurch, J ^a   McBride, H M ^a   Penfold, C A ^a   Fearon, D T ^a   Parkhouse, R M E ^a   Klaus, G G B ^a   Glennie, M J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD40 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GROWTH INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; BINDING SITES, ANTIBODY; CELL DIVISION; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY TESTS, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FLUORESCEINS; FLUORESCENT DYES; IMMUNIZATION, PASSIVE; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; SIGNAL TRANSDUCTION; SUCCINIMIDES; TUMOR CELLS, CULTURED;

EID: 0032530929     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)